I've added the emphasis...key points for me
1) Great additional data, adds to the set nicely.
2) CONSISTENCY, very important
3) Safety first - No AE's reported in last batch
4) Affirmation Q3 SAS Revenue (maybe modest, but still revenue) is possible in this area.
- Forums
- ASX - By Stock
- PAR
- Ann: Consistent pain reduction and improvement in function data
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
4.17%
!
40.3¢

Ann: Consistent pain reduction and improvement in function data, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
40.3¢ |
Change
-0.018(4.17%) |
Mkt cap ! $160.9M |
Open | High | Low | Value | Volume |
41.5¢ | 41.5¢ | 40.0¢ | $103.5K | 254.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 277 | 41.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 42 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 277 | 0.415 |
6 | 41245 | 0.400 |
3 | 41379 | 0.395 |
8 | 61459 | 0.390 |
2 | 29000 | 0.385 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 42 | 1 |
0.405 | 7556 | 1 |
0.410 | 57910 | 3 |
0.415 | 37799 | 2 |
0.420 | 55304 | 2 |
Last trade - 15.59pm 21/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |